Stocks
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -20.0 | 0.63 | 0.62 | 36.4 | -3.63 | 17.8 | ||
| Changes by years, y/y, % | -27% | -103% | -2% | +5 817% | -110% | -33.3% | |||
Sarepta Therapeutics. EV/EBITDA
Sarepta Therapeutics. EV/EBITDA, changes, %
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -66.0 | 61.8 | -12.9 | -3.80 | 21.4 | 17.8 | |
| Changes by years, y/y, % | +55 399% | -8 389% | -120% | -110% | -132% | |||
| Changes by quarters, q/q, % | -279% | -194% | -121% | -71% | -662% | |||
